(Q74537557)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9584621%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

Dizocilpine (MK801): use or abuse? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9584621%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9584621%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Taco J De Vries

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9584621%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

A N Schoffelmeer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9584621%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A H Mulder

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9584621%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9584621%20AND%20SRC:MED&resulttype=core&format=json

Trends in Pharmacological Sciences

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9584621%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9584621%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9584621%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

79-81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9584621%20AND%20SRC:MED&resulttype=core&format=json

Cellular and molecular mechanisms of drug dependence

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

The neural basis of drug craving: an incentive-sensitization theory of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

MK-801 disrupts the expression but not the development of bromocriptine sensitization: a state-dependency interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Competitive and non-competitive N-methyl-D-aspartate antagonists fail to prevent the induction of methamphetamine-induced sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

The NMDA receptor and cocaine: evidence that MK-801 can induce behavioral sensitization effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Evidence for dissociable mechanisms of amphetamine- and stress-induced behavioral sensitization: effects of MK-801 and haloperidol pretreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

MK-801 prevents the development of behavioral sensitization during repeated morphine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Does dizocilpine (MK-801) inhibit the development of morphine-induced behavioural sensitization in rats?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Amphetamine behavioral sensitization and the excitatory amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Cocaine behavioral sensitization and the excitatory amino acids.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta- and kappa-opioid receptor regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Neurotransmitter regulation of dopamine neurons in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Differential effects of agents acting at various sites of the NMDA receptor complex in a place preference conditioning model

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Competitive NMDA receptor antagonist, CGP 40116, substitutes for the discriminative stimulus effects of ethanol.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Systemic pretreatment with MK-801 (dizocilpine) increases breaking points for self-administration of cocaine on a progressive-ratio schedule in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Localization of drug reward mechanisms by intracranial injections

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Respiratory effects of the N-methyl-D-aspartate (NMDA) antagonist, MK-801, in intact and vagotomized chronic cats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

R-(+)-HA-966, an antagonist for the glycine/NMDA receptor, prevents locomotor sensitization to repeated cocaine exposures.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901164-4

7 January 2021

10.1016/S0165-6147(97)01164-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9584621%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference